Author Archives: James

Jobs: Alcohol and Other Drugs Counsellors – Queensland

Alcohol and Other Drugs Counsellors

 

The Alcohol and Drug Foundation Queensland (ADFQ), is an established NGO delivering numerous programs and services concerned with reducing the individual and social harms associated with alcohol and drug use and promoting health-enhancing behavioural change.

 

We currently have vacancies for three suitably qualified and experienced AOD Counsellors, one based in Ayr, North Queensland and two based in the South Burnett Region in SW Queensland.

The South Burnett positions have a particular focus of Youth and Indigenous services.

 

Excellent salary and other benefits are on offer to the successful applicants, and relocation assistance may be available.

 

For further information on the roles, and to access the Position Description and Key Selection Criteria, go to www.adfq.org

 

For further info about the role please contact the Community Services Manager – Vanda Wieczorkowski 07-3834 0245 or email:vanda.wieczorkowski@adfq.org   

 

Jobs: Senior Research Fellow – Auckland

NATIONAL INSTITUTE FOR HEALTH INNOVATION, THE UNIVERSITY OF AUCKLAND, NEW ZEALAND – SENIOR RESEARCH FELLOW IN ADDICTIONS

POSITION – The National Institute for Health Innovation (NIHI) at the University of Auckland’s School of Population Health invites applications for an experienced research position at the rank of Senior Research Fellow.

QUALIFICATIONS – Candidates for the position must have a doctoral degree in the area of epidemiology or public health and/or relevant professional qualification. with at least two years of experience in a previous relevant position. All research interests related to behavioral and community health, including medicine, will be considered. The successful candidate must demonstrate a record of scholarship and professional achievement, a good publication record, and evidence of success in obtaining grant funding. Preference will be given to candidates who have a demonstrated commitment to community-based research and practice, publications and an ability to initiate and implement new research projects.

RESPONSIBILITIES – The primary objective will be to initiate the development of new research ideas within the Addictions area of research. In this varied and interesting position, key tasks will include initiating new research ideas through the development of projects, writing grant applications, designing and assisting with the conduct of research studies, working with relevant parties to ensure the initial set up of a study is successful, and writing research publications for submission to refereed journals. The successful applicant must have working experience with statistical and word processing packages, experience in project management, team leadership and teaching, and it is preferred they have experience designing and running phase III clinical trials, ideally in smoking cessation/tobacco control and/or alcohol.

COMPENSATION AND RANK – This is a 2 year month Fixed Term position based at the University of Auckland. Ideally the successful candidate would be available to start in April 2013. Rank and compensation are commensurate with qualifications and experience.

INSTITUTE – NIHI is a multi-disciplinary group of health researchers with an international reputation for studies into the causes, prevention and treatment of health problems. NIHI has particular strengths in interventions research, especially in behavioural, community change and policy strategies, addictions, nutrition and physical activity and chronic disease prevention, treatment and management. A fast growing area of leadership is in the areas of health information technology, specifically mHealth and ‘big data’. NIHI researchers collaborate with other departments in the School of Population Health, other Schools within the faculty of Medical and Health Sciences, and other university Faculties. NIHI has wide international networks and active collaborations with leading researchers and research groups around the world, with a growing focus on low and middle-income nations. NIHI is managed by Auckland UniServices Ltd, the largest research and development company in the Southern Hemisphere, and a wholly owned arm of The University of Auckland. Further details about NIHI can be seen on our website – www.nihi.auckland.ac.nz

ADDICTIONS RESEARCH AT NIHI – The Addiction Research Programme at NIHI primarily focuses on tobacco control and smoking cessation research. Although New Zealand has made great progress over the past 60 years in reducing the prevalence of smoking, a ‘business as usual’ approach to tobacco control in New Zealand will not be sufficient to reach the government’s 2025 target to be a smokefree nation – thus, bold, innovative strategies are required. The NIHI Addiction team’s focus is on reducing tobacco demand through improving access to and determining the effectiveness of cessation products and strategies. The group specialises in the conduct of large, community-based phase III clinical trials. Examples of the types of research undertaken can be found here – http://www.nihi.auckland.ac.nz/page/our-addiction-research. The group is also developing expertise around interventions for alcohol.

UNIVERSITY – The University of Auckland is New Zealand’s largest, most successful and highest ranked university. The University is located in Auckland, a coastal city of 1.5 million people with a very moderate, coastal climate.

APPLICATION PROCEDURES – Interested candidates should submit a cover letter describing their background and experience, a curriculum vitae including grant-funded research and publications, and contact information for three referees to:

Chris Bullen, MB ChB, MPH (Hons), Ph.D.
Director and Associate Professor in Public Health
National Institute for Health Innovation
The University of Auckland
School of Population Health
Private Bag 92019
Auckland Mail Centre
Auckland
NEW ZEALAND
Phone: +6493737599 ext 84730
Email: c.bullen@nihi.auckland.ac.nz

 

ReGen queries new hospital-based AOD positions

ReGen queries alcohol and other drug focus for Victorian Emergency Departments

 

Melbourne, VIC, 25th January 2013 – UnitingCare ReGen (formerly Moreland Hall), the lead alcohol and other drug treatment and education agency of UnitingCare Victoria & Tasmania, today welcomed the announcement of $12 million of new funding in employing ‘drug liaison workers’ to reduce alcohol and other drug related violence in Victorian Emergency Departments (‘Hospitals overhauled to cope with drug and alcohol violence’, Herald Sun, Jan 25), but questioned the project’s capacity to support systemic responses to alcohol and other drug related harm.

 

Announced as part of the newly released Victorian whole of government strategy to reduce the impact of alcohol and drug abuse on the Victorian community, the move forms a key component of the Baillieu government’s reform of the state’s alcohol and other drugs treatment sector.

 

Donna Ribton-Turner, ReGen’s Clinical Services Director, queried whether the money could have been directed towards programs that would produce more sustainable benefits for the community:

 

While we welcome the initiative, it’s disappointing to learn that when Victorian alcohol and other drug treatment providers have been repeatedly told that there will be no new funding for services, we now see $12 million being directed towards a program that does not appear to improve the availability of treatment in Victoria.  Instead of only focussing on redirecting people out of the hospital system, it would have been encouraging to see  funding that could be used to increase hospitals’ capacity to identify and respond to alcohol and other drug harms within their own services. 

 

Victoria’s hospitals are already full of people who engage in problematic alcohol and other drug use.  They are not the people who present intoxicated in Emergency Departments, but those admitted for other conditions.  As a rule, hospitals have little knowledge of the true prevalence of substance use amongst their patients because many do not include it in their standard assessment procedures.  There is a solid body of evidence highlighting the effectiveness of introducing standard alcohol and other drugs screening and intervention programs in hospitals, when staff are trained and supported in their delivery.

 

Alcohol and other drug related violence in our hospitals is unacceptable and needs to be addressed.  However, it is only the tip of the iceberg.  The Emergency Department funding ignores the far bigger problem facing hospitals, treatment services and the wider community.  It begs the question, if the new ‘drug liaison workers’ succeed in referring large numbers of people to treatment services, how are already overstretched services expected to respond?

 

Ms Ribton-Turner continued:

 

The focus on violence does not address the contributing factors.  It also distorts the community’s perception of the challenges posed by alcohol and other drug use in our community and of the people involved.  ReGen’s community-based services work with nearly 2,000 individuals every year and incidents of violence are very, very rare.

 

We hope that, as the Victorian whole of government strategy is rolled out, we see more of a focus on strategies to increase the treatment sector’s capacity to reduce the impact of alcohol and other drugs on individuals, families and the wider community.

Jobs: Family Drug Support Project Officer – Sydney

PROJECT OFFICER – PART TIME

Family Drug Support is seeking a Project Officer to work on our ‘Bridging the Divide’ project 3.5 days per week.  The role is to create partnerships with drug treatment services to increase their capacity to work effectively with families.  The primary aim is to improve the efficacy of drug treatment by involving and supporting families of the alcohol/drug user.

 

Location of the position:  situated in Sydney and covering regional NSW areas and ACT

Qualifications:  Tertiary qualifications in psychology, social work or other relevant social science.

 

Remuneration:  A generous salary will be negotiated.   A one year contract will be offered.

 

Please send expression of interest or resume to:

Mr T Trimingham

CEO

Family Drug Support

PO Box 7363

Leura NSW 2780

e: admin@fds.ngo.org.au

w: www.fds.org.au        

 

Applications close on 11 February 2013

Jobs: Family Drug Support Project Officer – Melbourne

PROJECT OFFICER

Family Drug Support is seeking a Project Officer to work on our ‘Bridging the Divide’ project 3.5 days per week.  The role is to create partnerships with drug treatment services to increase their capacity to work effectively with families.  The primary aim is to improve the efficacy of drug treatment by involving and supporting families of the alcohol/drug user.

 

Location of the position:  Situated in Melbourne with expectations of covering regional Victoria, SA and Tasmania

 

Qualifications:  Tertiary qualifications in psychology, social work or other relevant social science.

 

Remuneration:  A generous salary will be negotiated.   A one year contract will be offered.

 

Please send expression of interest or resume to:

Mr T Trimingham

CEO

Family Drug Support

PO Box 7363

Leura NSW 2780

e: admin@fds.ngo.org.au

w: www.fds.org.au        

 

Applications close on 11 February 2013

2013 National Drug and Alcohol Awards

NDAA Media Release (29 January 2013).- NOMINATIONS OPEN FOR NATIONAL DRUG AND ALCOHOL AWARDS: Nominations have opened for the 2013 National Drug and Alcohol Awards (NDAA) which will be presented at Parliament House in Canberra on Thursday night, 20 June 2013.

The NDAAs are a highlight of the annual Drug Action Week and encourage, recognise, and celebrate achievements of the many people and organisations that do exceptional work to reduce the harm and impact of alcohol and other drugs in Australia. The 2013 Awards are being hosted by the Alcohol and other drugs Council of Australia (ADCA) and are open to all people and organisations working across the health and wellbeing sectors.

The NDAA website at www.drugawards.org.au has been re-designed with the aim of making it easier to navigate, and more user friendly with regard to nominating individuals, organisations, or programs for one or more of the nine Award Categories for 2013. A How to Nominate page summarises the nomination process, and is supported by specific information/ criteria which can be easily accessed by clicking on the relevant Category (at left of screen).

The website also provides comprehensive information about current/ past media releases, previous Award winners, and the 2012 Awards night in Melbourne. There are also vital links to the sponsors of the Awards, without whose support the coordinating committee would be unable to stage the Awards; NDAA contacts, and the Coordinating Committee partners – ADCA, the Australian National Council on Drugs (ANCD), the Australian Drug Foundation (ADF), and the Ted Noffs foundation (TNF).

The Prime Minister’s Award is the standout feature of the Award Categories which include Excellence in Prevention and Community Education, Excellence in Treatment and Support, Excellence in Research, Excellence in Services for Young People, Excellence in Law Enforcement, Excellence in Alcohol and Other Drug Media Reporting, Excellence in School Drug Education, and Excellence in Creating Healthy Sporting Communities.

The NDAA Honour Roll recognises individuals who have made a significant contribution, over a considerable time period, to the alcohol and other drugs field. The goal of the Honour Roll is to acknowledge and publicly recognise the exceptional work done by individuals who have strived tirelessly over a number of years to make a difference in the sector. Nominations may be made for people who have, or are currently working directly in the alcohol and other drugs field, or in the many related fields.

It should be noted that nominations can be completed using the nomination form which follows the criteria listing in each Category – the nomination can be lodged electronically, with supporting hard copy evidence (ie published materials, videos/ DVDs/ sound grabs) to be sent by post to Mr Brian Flanagan, NDAA Event Manager, ADCA, PO Box 269 Woden ACT 2606.

Please note that nominations for all Award following Categories are scheduled to close on Tuesday, 30 April 2013.

Jobs: AOD Clinician, TruckiesHelp – Sydney

ADIS is implementing a new program specifically focussed around substance use and health for long haul truck drivers.  A 24/7 service, TruckiesHelp will deliver one off and ongoing support for truckies via telephone and social media.  We are looking for experienced AOD Clinicians to work in the program, initially overnight, then moving into a rotating roster.

Details can be found here http://www.careersatsvmhs.com.au/main/jobsearch

Applications close 18/1/13.

ANCD Consultation in Brisbane

Dr John Herron, Chairman of the Australian National Council on Drugs (ANCD) extends an invitation to people working within the alcohol and other drugs sector to attend a:

Consultation on Drug and Alcohol Issues in Brisbane on:

Tuesday 19 February

9:00 – 11.15am

(Arrival tea and coffee from 8.30am, morning tea provided at 10.45am)

To be held at The Mercure Brisbane

85 – 87 North Quay
Brisbane, QLD

 

The ANCD is seeking views from non-government, community based, government, education, health and law enforcement staff on alcohol and other drugs issues in Queensland.

 

This is your chance to have your voice heard on issues that are important to you, your organisations and your community. The forum aims to be a collage of opinions, ideas and resolutions across a range of areas. The conclusions from the forum will be reported in the ANCD Communiqué which is sent to a number of key decision makers and stakeholders and placed on the ANCD website.

 

The Australian National Council on Drugs is the principal advisory body to Government on drug policy and plays a critical role in ensuring the voice of the community is heard in relation to drug related policies and strategies.

Please feel free to forward this invitation to other relevant people.

 

RSVP by Tuesday 12 February 2013

Tel: (02) 6166 9600    Fax: (02) 6162 2611    Email: ancd@ancd.org.au

Jobs: Counsellor and Educator, Victoria

2 exciting opportunities to join ReGen.

 

  • ·         AOD Counsellor based in Port Phillip Prison
  • ·         AOD Education and Activities Worker based in our adult residential withdrawal unit

 

Details can be found on our website at http://www.regen.org.au/employment/22-current-employment

 

ReGen is the lead alcohol and other drugs (AOD) treatment and education agency of UnitingCare Victoria and Tasmania. In June 2012 we changed our name from UnitingCare Moreland Hall to UnitingCare ReGen to give people a better idea of who we are, what we do and how we work.

Our purpose is to promote health and reduce alcohol and other drugs (AOD)-related harm.  We recognise that AOD use may not be the only issue that our clients are dealing with and we provide individualised treatment, education and support to enhance their lives and reduce harm.  In combination with our workforce training and public advocacy, we support social justice and sustainable change at an individual, community and systemic level.

Stats on Alcohol, Amphetamine and Mental Illness Admissions

Odyssey House media release – 18 December 2012

 

Alcohol, amphetamines and mental illness top admissions to rehab

 

Mental illness now affects more than half of all clients seeking treatment for alcohol and other drug dependence according to a report released today by one of Australia’s largest rehabilitation services.

 

The 2012 Odyssey House Annual Report also reveals alcohol remains the primary drug of concern for almost one in three people entering its residential rehabilitation program, with similar admission rates for amphetamine-type stimulants (ATS) such as ice and speed.

 

Opiates such as heroin, methadone, morphine and buprenorphine were the primary drug of concern for one in four clients during the 2011-2012 financial year.

 

Odyssey House CEO James Pitts said the link between increased mental illness and drug dependence, particularly alcohol and synthetic stimulants, highlights a significant public health issue that cannot be ignored.

 

“Drug dependence combined with mental illness has increased by 33 per cent over the past year, with 56 per cent of Odyssey House clients now diagnosed with conditions such as depression, anxiety, bipolar disorder, personality disorders or post-traumatic stress disorder.

 

“This compares with 42 per cent in 2011, but what’s particularly alarming is that it’s a five-fold increase since 1999, when 10 per cent of our clients had a diagnosed mental illness.”

 

Mr Pitts said a person’s mental illnesses may be pre-existing, exacerbated by drug misuse, a consequence of alcohol or other drug use, or symptomatic of withdrawal.

 

“What’s ironic is that people often turn to alcohol and other drugs in an attempt to feel better, have a good time or ‘self-medicate’ their personal issues, yet many end up in the grip of dependence and suffering serious mental health problems, sometimes long-term,” he said.

 

“For example, the psychiatric ‘bible’ DSM-IV-TR describes ten amphetamine-related disorders due to ATS intoxication or long-term use.

 

“In addition, ceasing ATS use may cause rebound depression, paranoid or suspicious thoughts, agitation, irritability and sleep disorders for weeks or months, which poses significant treatment challenges.

 

“Treating people suffering drug dependence and mental illness requires a comprehensive and coordinated approach to recovery on both fronts.”

 

Odyssey House clients access psychiatric services and prescribed medication and also participate in a specific dual diagnosis therapy group, which helps them understand and manage their condition and avoid relapse to mental illness and substance misuse.

 

However, there are no medications proven to effectively treat ATS dependence, and opiate and alcohol treatment methodologies may not be effective for ATS users.

 

Accordingly, Odyssey House participated in a rigorous longitudinal trial[1] of an intensive therapy-based treatment developed for people suffering ATS dependence, which also takes into account their likely psychological problems and issues such as disordered thoughts, trouble focusing and issues with motivation and engagement in therapy. Early results are promising and findings are expected to be published in 2013.

 

Snapshot of key statistics, 2012 Odyssey House Annual Report

 

Residential Rehabilitation Program

 

  • Drug dependence combined with mental illness increased by 33 per cent over the past year, with 56 per cent of Odyssey House clients diagnosed with a mental illness

 

  • During the 2011-12 financial year, alcohol was the primary drug of concern for 29 per cent of clients admitted to the Odyssey House Residential Program (30% in 2011); 70 per cent of clients list alcohol as one of their drugs of concern.

 

  • Thirty per cent of clients reported amphetamine-type stimulants (ATS) as their main drug of concern, an increase of 20 per cent on 2011, when 25 per cent cited ATS.

 

  • Admissions for opiates, predominantly heroin, accounted for 24 per cent of admissions, down from 27 per cent in 2011.

 

  • Fifteen per cent of admissions were for cannabis, a rate unchanged since 2011 and with only minor variations over the past ten years.

 

  • During the year, 643 people were admitted to the Odyssey House Residential Program, including the Parents’ and Children’s Program, where families live together while the parents undertake rehabilitation and learn parenting skills. Nineteen children aged from 0 to 11 years benefited from their parents’ participation in the program during the year.

 

  • While young people continue to represent a significant proportion of admissions, there is a continuing upward trend in the age of the people Odyssey House serves: clients aged 31 years and over comprised two-thirds (62%) of residential admissions in 2012, including 25 per cent who were 41 years and over. Seven in ten clients were male.

 

Withdrawal Unit

 

  • The Odyssey House Withdrawal Unit admitted 327 people for short-term medically supervised withdrawal services during the year and almost half of completing clients went on to enter the Residential Program (clients are referred to services most suited to their rehabilitation needs, which may include out-patient counselling or support groups).

 

  • While amphetamine-type stimulants were also a concern for clients entering the Odyssey House Withdrawal Program (22%), dependence on opiates accounted for 42 per cent of clients seeking medically supervised withdrawal services during the year.

 

  • Alcohol was the primary drug of concern for 15 per cent of withdrawal clients, while cannabis dependence accounted for 17 per cent of withdrawal admissions.

 

In 2011-2012, Odyssey House residents accounted for over 33,256 drug-free and crime-free days. This amounted to a cost saving to society of more than $18 million.

 

Odyssey House has assisted more than 35,000 people to overcome dependence on alcohol and other drugs since 1977. The Odyssey House Admissions Centre can be contacted on 02 9281 5144 (no referral is necessary) or visit www.odysseyhouse.com.au.